EQT has announced that the EQT Mid Market Europe fund has agreed to sell Fertin Pharma, a specialist CDMO in innovative oral and intra-oral delivery technologies, to Philip Morris International Inc. for an enterprise value of DKK 5.1 billion. Headquartered in Vejle, Denmark, Fertin Pharma is a specialist CDMO in innovative oral and intra-oral delivery…